Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Short Interest Update

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) was the target of a significant decline in short interest in the month of December. As of December 31st, there was short interest totaling 201,506 shares, a decline of 45.4% from the December 15th total of 369,147 shares. Approximately 12.4% of the shares of the company are sold short. Based on an average daily volume of 306,643 shares, the short-interest ratio is presently 0.7 days. Based on an average daily volume of 306,643 shares, the short-interest ratio is presently 0.7 days. Approximately 12.4% of the shares of the company are sold short.

Defiance Daily Target 2X Long LLY ETF Price Performance

NYSEARCA:LLYX traded up $0.21 during mid-day trading on Friday, reaching $23.48. The stock had a trading volume of 434,168 shares, compared to its average volume of 456,949. The business has a 50 day simple moving average of $25.05 and a 200 day simple moving average of $18.33. Defiance Daily Target 2X Long LLY ETF has a twelve month low of $9.60 and a twelve month high of $28.44.

Defiance Daily Target 2X Long LLY ETF Announces Dividend

The firm also recently declared an annual dividend, which was paid on Wednesday, December 31st. Shareholders of record on Tuesday, December 30th were issued a $0.7042 dividend. This represents a dividend yield of 273.0%. The ex-dividend date of this dividend was Tuesday, December 30th.

Defiance Daily Target 2X Long LLY ETF Company Profile

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.